๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Topoisomerase II-alpha gene deletion is not frequent as its amplification in breast cancer

โœ Scribed by Kyeongmee Park; Sehwan Han; Geum-Hee Gwak; Huyn-jung Kim; Jungyeon Kim; Kyoung-Mee Kim

Book ID
106377071
Publisher
Springer US
Year
2006
Tongue
English
Weight
202 KB
Volume
98
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Characterization of topoisomerase IIฮฑ ge
Characterization of topoisomerase IIฮฑ gene amplification and deletion in breast cancer
โœ Tero A.H. Jรคrvinen; Minna Tanner; Maarit Bรคrlund; ร…ke Borg; Jorma Isola ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 311 KB ๐Ÿ‘ 1 views

Topoisomerase IIโฃ (TOP2A) is a key enzyme in DNA replication and a molecular target for many important anticancer drugs. TOP2A is amplified or deleted together with amplification of the closely located ERBB2/HER-2/neu oncogene in breast cancer. We characterized the copy number aberrations of TOP2A a

Amplification of the TOP2A gene does not
Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples
โœ Rosemary E. Mueller; Robert K. Parkes; Irene Andrulis; Frances P. O'Malley ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 387 KB

Recent clinical trials have suggested that patients whose breast tumors overexpress HER2 may derive particular benefit from anthracycline-containing chemotherapy compared to that without anthracycline. It has been proposed that the HER2 gene amplification reported in these tumors might mask an under